Devyser Diagnostics AB (publ) (STO:DVYSR)
147.00
+2.00 (1.38%)
Sep 10, 2025, 11:49 AM CET
Devyser Diagnostics AB Revenue
Devyser Diagnostics AB had revenue of 67.40M SEK in the quarter ending June 30, 2025, with 26.69% growth. This brings the company's revenue in the last twelve months to 235.10M, up 19.89% year-over-year. In the year 2024, Devyser Diagnostics AB had annual revenue of 216.90M with 28.12% growth.
Revenue (ttm)
235.10M
Revenue Growth
+19.89%
P/S Ratio
10.23
Revenue / Employee
1.99M
Employees
121
Market Cap
2.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 216.90M | 47.60M | 28.12% |
Dec 31, 2023 | 169.30M | 42.70M | 33.73% |
Dec 31, 2022 | 126.60M | 33.12M | 35.43% |
Dec 31, 2021 | 93.48M | 27.79M | 42.31% |
Dec 31, 2020 | 65.69M | 1.39M | 2.16% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.97B |
Sectra AB | 3.37B |
Getinge AB | 35.50B |
Camurus AB | 2.27B |
Medicover AB | 25.22B |
Asker Healthcare Group AB | 15.88B |
BioArctic AB | 1.86B |
AddLife AB | 10.44B |